Cardio Diagnostics Holdings, Inc. has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as part of its Schedule 14A Proxy Statement. This filing, pursuant to Section 14(a) of the Securities Exchange Act of 1934, indicates that the materials are intended for use in connection with a shareholder meeting or to solicit proxies. The company has confirmed that no filing fee is required for this submission. The definitive additional materials suggest that Cardio Diagnostics Holdings is preparing for upcoming corporate actions that require shareholder votes, although the specific resolutions or proposals are not detailed in this announcement.

Cardio Diagnostics Holdings, Inc. has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as part of its Schedule 14A Proxy Statement. This filing, pursuant to Section 14(a) of the Securities Exchange Act of 1934, indicates that the materials are intended for use in connection with a shareholder meeting or to solicit proxies. The company has confirmed that no filing fee is required for this submission. The definitive additional materials suggest that Cardio Diagnostics Holdings is preparing for upcoming corporate actions that require shareholder votes, although the specific resolutions or proposals are not detailed in this announcement.